Sign in to view content

Intravitreal Aflibercept 8 mg in Patients With Polypoidal Choroidal Vasculopathy Phase 3 PULSAR Trial Subgroup Analysis

David T.W. Wong, MD, FRCS(C), FASRS

Video
Published 2023

Related

Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA
Nathan C. Steinle, MD
Annual Meeting Talks
2020
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020
Submacular Hemorrhage
Pauline T. Merrill, MD, FASRS
Retina Image Bank: Images of the Week
2018

Category: AMD-Neovascular

See more